Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Uganda and the continent in general, shoulders a heavy disease burden yet the world scientific output focused on African countries remains largely small estimated at less than 1 per cent.
We previously reported on patent infringement litigations between Alnylam and Moderna. Below we provide updates on two proceedings involving the mRNA vaccine producer Moderna.
BioNTech would initiate an early-to-mid stage trial for the vaccine program BNT166 to prevent mpox, a viral illness that causes skin rashes and could be transmitted to humans through physical contact. The vaccine candidates are based on the same messenger-RNA (mRNA) technology which has been used in its COVID shots developed with partner Pfizer. The partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) also aims to contribute to its mission to accelerate development of vaccines to be ready for regulatory authorization and manufacturing at scale within 100 days of recogn...
BioNTech would initiate an early-to-mid stage trial for the vaccine program BNT166 to prevent mpox, a viral illness that causes skin rashes and could be transmitted to humans through physical contact. The vaccine candidates are based on the same messenger-RNA (mRNA) technology which has been used in its COVID shots developed with partner Pfizer. The partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) also aims to contribute to its mission to accelerate development of vacc
WILMINGTON, Del., Sept. 17, 2023 (GLOBE NEWSWIRE) -- In the ever-evolving landscape of construction, AC3D is pushing the boundaries of what's possible...